Cargando…
Can psychedelics enhance group psychotherapy? A discussion on the therapeutic factors
BACKGROUND: Despite the growth of psychedelic research, psychedelic-assisted group psychotherapy (PAGP) has received little attention in comparison to individual psychedelic-assisted psychotherapy models. METHODS: In this article, we aim to discuss the therapeutic potential of PAGP, as well as outli...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350738/ https://www.ncbi.nlm.nih.gov/pubmed/36855289 http://dx.doi.org/10.1177/02698811231155117 |
_version_ | 1785074209703067648 |
---|---|
author | Ponomarenko, Polina Seragnoli, Federico Calder, Abigail Oehen, Peter Hasler, Gregor |
author_facet | Ponomarenko, Polina Seragnoli, Federico Calder, Abigail Oehen, Peter Hasler, Gregor |
author_sort | Ponomarenko, Polina |
collection | PubMed |
description | BACKGROUND: Despite the growth of psychedelic research, psychedelic-assisted group psychotherapy (PAGP) has received little attention in comparison to individual psychedelic-assisted psychotherapy models. METHODS: In this article, we aim to discuss the therapeutic potential of PAGP, as well as outline existing models and the challenges of this approach. Using Irvin Yalom’s 11 therapeutic factors of group therapy as a basic framework, we analyse current literature from clinical studies and neurobiological research relative to the topic of PAGP. RESULTS: We argue that combining psychedelic substances and group psychotherapy may prove beneficial for increasing group connectedness and interpersonal learning, potentially enhancing prosocial behaviour with direct opportunities to practice newly acquired knowledge about previously maladaptive behavioural patterns. Challenges regarding this approach include a more rigid therapy structure and potential loss of openness from patients, which may be ameliorated by adequate therapeutic training. CONCLUSION: We hope for this article to support clinical research on PAGP by presenting a therapeutic framework and outlining its mechanisms and challenges. |
format | Online Article Text |
id | pubmed-10350738 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-103507382023-07-18 Can psychedelics enhance group psychotherapy? A discussion on the therapeutic factors Ponomarenko, Polina Seragnoli, Federico Calder, Abigail Oehen, Peter Hasler, Gregor J Psychopharmacol Perspectives BACKGROUND: Despite the growth of psychedelic research, psychedelic-assisted group psychotherapy (PAGP) has received little attention in comparison to individual psychedelic-assisted psychotherapy models. METHODS: In this article, we aim to discuss the therapeutic potential of PAGP, as well as outline existing models and the challenges of this approach. Using Irvin Yalom’s 11 therapeutic factors of group therapy as a basic framework, we analyse current literature from clinical studies and neurobiological research relative to the topic of PAGP. RESULTS: We argue that combining psychedelic substances and group psychotherapy may prove beneficial for increasing group connectedness and interpersonal learning, potentially enhancing prosocial behaviour with direct opportunities to practice newly acquired knowledge about previously maladaptive behavioural patterns. Challenges regarding this approach include a more rigid therapy structure and potential loss of openness from patients, which may be ameliorated by adequate therapeutic training. CONCLUSION: We hope for this article to support clinical research on PAGP by presenting a therapeutic framework and outlining its mechanisms and challenges. SAGE Publications 2023-02-28 2023-07 /pmc/articles/PMC10350738/ /pubmed/36855289 http://dx.doi.org/10.1177/02698811231155117 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution 4.0 Lficense (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Perspectives Ponomarenko, Polina Seragnoli, Federico Calder, Abigail Oehen, Peter Hasler, Gregor Can psychedelics enhance group psychotherapy? A discussion on the therapeutic factors |
title | Can psychedelics enhance group psychotherapy? A discussion on the therapeutic factors |
title_full | Can psychedelics enhance group psychotherapy? A discussion on the therapeutic factors |
title_fullStr | Can psychedelics enhance group psychotherapy? A discussion on the therapeutic factors |
title_full_unstemmed | Can psychedelics enhance group psychotherapy? A discussion on the therapeutic factors |
title_short | Can psychedelics enhance group psychotherapy? A discussion on the therapeutic factors |
title_sort | can psychedelics enhance group psychotherapy? a discussion on the therapeutic factors |
topic | Perspectives |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350738/ https://www.ncbi.nlm.nih.gov/pubmed/36855289 http://dx.doi.org/10.1177/02698811231155117 |
work_keys_str_mv | AT ponomarenkopolina canpsychedelicsenhancegrouppsychotherapyadiscussiononthetherapeuticfactors AT seragnolifederico canpsychedelicsenhancegrouppsychotherapyadiscussiononthetherapeuticfactors AT calderabigail canpsychedelicsenhancegrouppsychotherapyadiscussiononthetherapeuticfactors AT oehenpeter canpsychedelicsenhancegrouppsychotherapyadiscussiononthetherapeuticfactors AT haslergregor canpsychedelicsenhancegrouppsychotherapyadiscussiononthetherapeuticfactors |